Infinitt, Intelerad Top KLAS List of PACS Innovators
Infinitt and Intelerad rose to the top among PACS vendors who offer timely upgrades and expanded usability, according to a KLAS report released at RSNA 2012.
CHICAGO - Infinitt and Intelerad rose to the top among PACS vendors who offer timely upgrades and expanded usability, according to a KLAS report.
As demand for PACS has grown, so has the need for vendors to differentiate themselves, according to the report which shares customer feedback. Other top-rated vendors endorsed by their customers include DR Systems, McKesson, Novarad, and Sectra, according to KLAS.
"The top-rated PACS innovators have a track record of improvement," Ben Brown, report author and KLAS research director, said in a statement. "The vendors that land in the middle tier of this study offer solid technology and innovation, but at a slower pace. Vendors in that group are meeting most of providers' expectations, but they are not exceeding them like the top-tier vendors are."
Middle-tier vendors are Carestream, Fuji, Merge, and Philips, according to KLAS. Vendor success in meeting customer’s needs varies among these vendors. Although Fuji and Carestream are reputable global PACS vendors, customers reported wanting greater development. Philips is playing catch-up, and Merge's development speed has been impacted by their focus on consolidating their PACS portfolio, according to KLAS.
Some vendors are falling behind when it comes to development and functionality, including Agfa, Cerner, GE, and Siemens, which KLAS said fall in the bottom tier of PACS innovators. However, the vendors in this group offer some stability and integration. Cerner and Siemens customers cited lack of functionality, which has not been completely solved with upgrades, and Agfa and GE customers noted their solutions are scalable and stable, but upgrades are not keeping pace with the innovation.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
